# Feasibility of Using Contrast Enhanced Voiding Urosonography (CeVUS) During Urodynamic Studies

> **NCT04170413** · — · COMPLETED · sponsor: **University of Virginia** · enrollment: 25 (actual)

## Conditions studied

- Neurogenic Bladder

## Interventions

- **DRUG:** CeVUS

## Key facts

- **NCT ID:** NCT04170413
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2020-11-02
- **Final completion:** 2020-11-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04170413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04170413, "Feasibility of Using Contrast Enhanced Voiding Urosonography (CeVUS) During Urodynamic Studies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04170413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*